Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
per week
for 24 weeks
// //

Medipharm Labs Corp TSX: LABS-T

Today's Change
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 0.4200
Day High 0.4400
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream, 2:1 CBD:THC, Pink Kush and GG4. Its geographical segments are Canada and Australia.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come
- PR Newswire - PRF - Fri Jul 9, 2:00PM CDT
PR Newswire - PRF - CMTX
Fri Jul 9, 2:00PM CDT
/PRNewswire/ --   -  As part of its recent cannabis M&A spree,  (NYSE: HEXO) (TSX: HEXO) spent nearly another billion dollars, acquiring  privately-owned licensed cannabis producer Redecan for . By adding Redecan, HEXO continues to grow its large portfolio of brands and production operations, as well as new cannabis 2.0 extraction-based products. Because of the size of the deal, the potential values of other Canadian cannabis brands, producers and extractors could be on the rise as additional M&A activity begins to swell in the leadup to potential legalization in the . Other Canadian companies that have been positioning themselves in this field include (OTC: PRXTF) (CSE: PULL) (XFRA: A2QJAJ),  (OTC: VLNCF) (TSX: VLNS),  (TSX: LABS) (OTC: MEDIF) and (NASDAQ: NEPT) (TSX: NEPT).
Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick Pace
- PR Newswire - PRF - Thu Apr 29, 8:15AM CDT
PR Newswire - PRF - CMTX
Thu Apr 29, 8:15AM CDT
, /PRNewswire/ -- The worldwide explosion of the recreational and medical cannabis markets, and submarkets, appears that it will continue for years to come. New industries have been born, new mega-companies are growing and other new worldwide players will undoubtedly emerge. When new industries with almost unlimited revenue growth rates appear, the companies need an edge on their competition to survive the consolidations and mergers, to come out on top. Sometimes that edge is having and protecting their IP… with patents. An  from a UK and European Patent and Trade Mark Attorney firm discussed the view from the UK. It said: "Following high profile legalisation in territories around the world (for example , some states in the US and limited medicinal allowability in the UK), industry and financial institutions are recognizing the commercial potential of cannabis… And where there is commercial potential, there will be a demand to protect innovations made to capitalize on the market. A quick search on a global patent database indicates over 7000 granted patents which include the word cannabis, including over 1000 in and UK.  However, given that recreational cannabis is presently illegal in many places (for example, most places in and federally in the US), can you patent something which is illegal? Additionally, since cannabis is natural and has been known since ancient times, can you patent something which is so well known?"  Active companies in news today include:  (OTCQB: OILFF) (CSE: OILS), (NASDAQ: GWPH), (OTCQX: MEDIF) (TSX: LABS),  (NASDAQ: CGC) (TSX: WEED), (OTCQX: VLNCF) (TSX: VLNS).
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market
- ACCESSWIRE - Tue Apr 13, 6:50AM CDT
Tue Apr 13, 6:50AM CDT
TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, announced that its subsidiary, Adjupharm GmbH ("Adjupharm"), recently signed a supply agreement (the "Supply Agreement") with MediPharm Labs Australia Pty Ltd, a subsidiary of MediPharm Labs Corp. ("MediPharm Labs") (TSX:LABS), (OTCQX:MEDIF), (FSE:MLZ), a global leader in specialized, research-driven, pharmaceutical-quality cannabis extraction, distillation and derivative products. The initial term of the Supply Agreement is two years, with a two-year automatic extension period.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.4100 +4.88% increase
on 07/28/21
Period Open:0.4500
Price movement based on the high, low and last over the given period.
0.4750 -9.47% decrease
on 07/14/21
-0.0200 (-4.44%) decrease
since 06/30/21
3-Month 0.3900 +10.26% increase
on 05/14/21
Period Open:0.4600
Price movement based on the high, low and last over the given period.
0.5800 -25.86% decrease
on 05/31/21
-0.0300 (-6.52%) decrease
since 04/30/21
52-Week 0.3900 +10.26% increase
on 05/14/21
Period Open:1.1000
Price movement based on the high, low and last over the given period.
1.2000 -64.17% decrease
on 09/03/20
-0.6700 (-60.91%) decrease
since 07/30/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies